FDA DEVICE FACTS
ADVIA Centaur CMV IgG and ADVIA Centaur CMV IgG Quality Control
Siemens Healthcare Diagnostics, Inc.
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
1. Intended use(s): ADVIA Centaur CMV lgG The ADVIA Centaur CMV IgG (CMV IgG) assay is for in vitro diagnostic use in the qualitative detection of IgG antibodies to cytomegalovirus (CMV) in human pediatric and adult serum and plasma (dipotassium EDTA, lithium heparin) using the ADVIA Centaur XP system. This assay is used to determine CMV IgG serological status and as an aid in the diagnosis of CMV infection in individuals for whom a CMV IgG test was ordered, including pregnant women. The ADVIA Centaur CMV IgG assay is not intended for blood and tissue donor screening. ADVIA Centaur CMV IgG Quality Control The ADVIA Centaur CMV IgG (CMV IgG) Quality Control material is for in vitro diagnostic use for monitoring the performance of the ADVIA Centaur CMV IgG (CMV IgG) assay on ADVIA Centaur systems.
2. Indication(s) for use: Same as Intended Use
3. Special conditions for use statement(s): N/A
4. Special instrument requirements: ADVIA Centaur XP system
I. Device Description: The ADVIA Centaur CMV IgG Assay is a fully automated, 2-step sandwich immunoassay using indirect chemiluminometric technology. The patient specimen is diluted with ADVIA Centaur CMV IgG Diluent and incubated with the Solid Phase reagent. The Solid Phase reagent contains a heterogeneous mixture of biotinylated CMV viral lysate antigens, preformed to streptavidin-coated magnetic particles. The antigen coated particles subsequently capture CMV specific antibodies in the specimen. The antibody-antigen complex is washed and detection reagent is added. The detection reagent consists of an acridinium-ester (AE)-labeled anti-human IgG mouse monoclonal antibody. The entire complex is washed and the signal is generated in the presence of Lite Reagent bound to the Solid Phase via the CMV IgG-CMV antigen complex. The system reports results according to the selected option, as described in the system operating Instructions.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。